ICU Medical, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Vivek Jain
- Full Time Employees
- 15,000
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 951 Calle Amanecer San Clemente CA United States of America 92673
- IPO Date
- Mar 31, 1992
- CIK
- 0000883984
- Website
- icumed.com
- Similar Companies
- Business
- ICU Medical, Inc. stands as a global medical technology company dedicated to developing, manufacturing, and distributing essential devices for infusion therapy and critical care applications worldwide. The company's comprehensive portfolio addresses patient safety, infection prevention, and optimized medication delivery across various healthcare settings. Within infusion therapy, ICU Medical offers an array of needle-free connection systems, including the MicroClave, MicroClave Clear, and NanoClave brands, designed to reduce infection risks. Its product range further encompasses catheter patency devices like Neutron, disinfecting caps such as SwabCap and SwabTip, and Tego hemodialysis connectors. For safe handling of hazardous medications, the company provides ChemoClave and ChemoLock closed system transfer devices, alongside the Diana hazardous drug compounding system. The company also specializes in intravenous solutions and irrigation products, offering a broad selection of injectables, diluents, and parenteral nutrition solutions in flexible containers. Its infusion pump technologies include the Plum 360 and the newly FDA-cleared Plum Duo infusion pumps, which build on cassette technology for precise medication delivery. These pumps are integrated with advanced IV medication safety software, such as ICU Medical MedNet and LifeShield, providing enterprise-class medication management, IV-EHR interoperability, and robust analytics to enhance patient safety and streamline clinical workflows. In critical care, ICU Medical delivers hemodynamic monitoring systems like Cogent and CardioFlo, along with TDQ and OptiQ cardiac output monitoring catheters. It also supplies TriOx venous oximetry catheters, Transpac blood pressure transducers, and SafeSet closed blood sampling and conservation systems. ICU Medical serves a diverse clientele, including acute care hospitals, wholesalers, ambulatory clinics, home health care providers, and long-term care facilities. The company has expanded its capabilities through strategic acquisitions, notably incorporating Hospira Infusion Systems in 2017 and Smiths Medical in 2022, broadening its product offerings in vascular access, vital care, and syringe and ambulatory infusion devices. Founded in 1984 by Dr. George A. Lopez, ICU Medical maintains its headquarters in San Clemente, California.
Implied Volatility Surging for ICU Medical Stock Options
ICU Medical, Inc. (ICUI) Q1 2026 Earnings Call Transcript
ICU Medical (ICUI) Tops Q1 Earnings and Revenue Estimates
ICU Medical Announces First Quarter 2026 Results
Madison Small Cap Fund Q1 2026 Portfolio Activity
ICU Medical (ICUI) Reports Next Week: Wall Street Expects Earnings Growth
ICU Medical Inc (ICUI) Stock Down 4.6% -- Now Undervalued? GF Score: 86/100
ICU Medical Announces Time of First Quarter 2026 Earnings Conference Call
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)
ICU Medical Calls Itself a “Pure-Play Infusion” Leader, Details Pricing, Pumps and Buyback Plans
ICU Medical Moving Toward A Cleaner Margin Leverage And Capital Return Story
Reviewing Sanara MedTech (NASDAQ:SMTI) & ICU Medical (NASDAQ:ICUI)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ICU Medical, Inc. (NASDAQ: ICUI)
Victory Capital Management Inc. Purchases 53,619 Shares of ICU Medical, Inc. $ICUI
ICU Medical to Participate in Upcoming Investor Conferences
ICU Medical, Inc. (ICUI) Q4 2025 Earnings Call Transcript
ICU Medical (ICUI) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
ICU Medical (ICUI) Q4 Earnings and Revenues Surpass Estimates
ICU Medical Announces Fourth Quarter 2025 Results and Provides Fiscal Year 2026 Guidance
Bryce Point Capital LLC Takes $586,000 Position in ICU Medical, Inc. $ICUI